Sesen Bio researches, discovers, develops and commercializes antibody-drug conjugate therapies for the treatment of cancer.Read more
Sesen Bio's revenue is the ranked 7th among it's top 10 competitors. The top 10 competitors average 44.7M. Over the last one quarters, Sesen Bio's revenue has decreased by 0%. Specifically, in Q4 2021's revenue was $20M.